Tìm theo
MBT-0312
Thuốc Gốc
Small Molecule
MediGene's newly acquired drug candidates MBT-0312 aim at a novel method of cancer therapy by "starving out" tumors.
Cơ Chế Tác Dụng : MediGene's newly acquired drug candidates MBT-0312 aim at a novel method of cancer therapy by "starving out" tumors. The already approved and accepted therapy of anti-angiogenesis (suppressing tumor vascularization), is complemented by MBT-0312. An innovative proprietary carrier system of lipid complexes facilitates a novel application method of established cytostatic drugs (e.g. Taxane), intended to cause specific attachment and destruction of tumor blood vessels ("neovascular targeting").
Chỉ Định : Investigated for use/treatment in solid tumors.
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB05880
... loading
... loading